Published 1 day ago • loading... • Updated 1 day ago

Samsung Biologics, Amgen and Biocon invest in US pharma sites

International drugmakers are securing domestic deals and investments as tariff pressures complicate trade and raise the cost of goods.

International drugmakers are securing domestic deals and investments as tariff pressures complicate trade and raise the cost of goods.

1 day ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated10 hours agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Manufacturing Dive broke the news in 1 day ago on Monday, September 15, 2025.

Sources are mostly out of (0)